Cell Reports (Apr 2014)

Linkage of DNA Methylation Quantitative Trait Loci to Human Cancer Risk

  • Holger Heyn,
  • Sergi Sayols,
  • Catia Moutinho,
  • Enrique Vidal,
  • Jose V. Sanchez-Mut,
  • Olafur A. Stefansson,
  • Ernest Nadal,
  • Sebastian Moran,
  • Jorunn E. Eyfjord,
  • Eva Gonzalez-Suarez,
  • Miguel Angel Pujana,
  • Manel Esteller

Journal volume & issue
Vol. 7, no. 2
pp. 331 – 338

Abstract

Read online

Summary: Epigenetic regulation and, in particular, DNA methylation have been linked to the underlying genetic sequence. DNA methylation quantitative trait loci (meQTL) have been identified through significant associations between the genetic and epigenetic codes in physiological and pathological contexts. We propose that interrogating the interplay between polymorphic alleles and DNA methylation is a powerful method for improving our interpretation of risk alleles identified in genome-wide association studies that otherwise lack mechanistic explanation. We integrated patient cancer risk genotype data and genome-scale DNA methylation profiles of 3,649 primary human tumors, representing 13 solid cancer types. We provide a comprehensive meQTL catalog containing DNA methylation associations for 21% of interrogated cancer risk polymorphisms. Differentially methylated loci harbor previously reported and as-yet-unidentified cancer genes. We suggest that such regulation at the DNA level can provide a considerable amount of new information about the biology of cancer-risk alleles. : An integrative study from Heyn et al. now provides a comprehensive catalog of DNA methylation quantitative trait loci of cancer-risk alleles associated with the most common solid tumor types. The authors demonstrate that DNA methylation linkage analysis is a powerful tool for functional interpretation of genetic risk variants identified in GWAS that otherwise lack mechanistic explanation. They suggest that such regulation represents a mediator trait that provides valuable information about the biology of cancer-risk alleles.